444.83

1.39% 6.10

Madrigal Pharmaceuticals Inc (MDGL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché MDGL Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$438.73

Aprire:

$440.64

Volume 24 ore:

220.74K

Relative Volume:

0.65

Capitalizzazione di mercato:

$10.10B

Reddito:

$958.40M

Utile/perdita netta:

$-288.28M

Rapporto P/E:

-34.58

EPS:

-12.8641

Flusso di cassa netto:

$-193.02M

1 W Prestazione:

+2.77%

1M Prestazione:

-4.28%

6M Prestazione:

+2.92%

1 anno Prestazione:

+37.71%

Intervallo 1D:

$434.30

$448.07

Intervallo di 1 settimana:

$418.72

$448.07

Portata 52W:

$265.00

$615.00

Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile

Nome

Madrigal Pharmaceuticals Inc

Settore

Healthcare (1116)

Industria

Biotechnology (621)

Telefono

404-380-9263

Indirizzo

200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA

Dipendente

528

Cinguettio

@MadrigalPharma

Prossima data di guadagno

2024-10-31

Ultimi documenti SEC

MDGL's Discussions on Twitter

Compare MDGL vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MDGL Madrigal Pharmaceuticals Inc	444.83	10.10B	958.40M	-288.28M	-193.02M	-12.86
VRTX Vertex Pharmaceuticals Inc	469.34	119.23B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	745.77	78.84B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	700.45	43.35B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	313.41	41.57B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	284.05	31.51B	5.36B	287.73M	924.18M	2.5229

Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-28	Iniziato	Barclays	Overweight
2026-01-06	Downgrade	Wolfe Research	Outperform → Peer Perform
2025-11-05	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2025-11-03	Aggiornamento	BofA Securities	Underperform → Neutral
2025-10-15	Iniziato	Truist	Buy
2025-09-04	Ripresa	H.C. Wainwright	Buy
2025-02-28	Aggiornamento	B. Riley Securities	Neutral → Buy
2025-02-27	Reiterato	H.C. Wainwright	Buy
2024-06-28	Iniziato	Cantor Fitzgerald	Neutral
2024-06-11	Iniziato	Wolfe Research	Outperform
2024-04-22	Iniziato	BofA Securities	Underperform
2024-03-15	Aggiornamento	B. Riley Securities	Sell → Neutral
2024-03-06	Iniziato	Citigroup	Buy
2024-02-26	Downgrade	B. Riley Securities	Neutral → Sell
2022-12-20	Reiterato	Oppenheimer	Outperform
2022-12-19	Reiterato	H.C. Wainwright	Buy
2022-12-19	Reiterato	Piper Sandler	Overweight
2022-12-19	Aggiornamento	Raymond James	Underperform → Mkt Perform
2022-07-08	Downgrade	B. Riley Securities	Buy → Neutral
2021-10-07	Iniziato	Jefferies	Buy
2021-08-06	Aggiornamento	BMO Capital Markets	Market Perform → Outperform
2021-05-20	Ripresa	Goldman	Buy
2020-11-24	Ripresa	Evercore ISI	Outperform
2020-11-06	Reiterato	H.C. Wainwright	Buy
2020-07-31	Iniziato	Piper Sandler	Overweight
2020-06-05	Iniziato	BMO Capital Markets	Market Perform
2020-05-05	Iniziato	Chardan Capital Markets	Buy
2020-01-30	Iniziato	Canaccord Genuity	Buy
2020-01-09	Aggiornamento	UBS	Neutral → Buy
2019-11-07	Reiterato	H.C. Wainwright	Buy
2019-06-25	Iniziato	Stifel	Hold
2019-06-10	Aggiornamento	B. Riley FBR	Neutral → Buy
2019-02-28	Reiterato	H.C. Wainwright	Buy
2019-02-22	Iniziato	SVB Leerink	Outperform
2019-01-23	Iniziato	UBS	Neutral
2018-12-14	Iniziato	Wolfe Research	Outperform
2018-12-12	Iniziato	B. Riley FBR	Neutral
2018-11-19	Downgrade	Raymond James	Mkt Perform → Underperform
2018-11-16	Aggiornamento	Evercore ISI	In-line → Outperform
2018-09-04	Iniziato	Citigroup	Buy
2018-08-06	Downgrade	Goldman	Buy → Neutral
2018-06-28	Iniziato	Raymond James	Mkt Perform

Mostra tutto

Madrigal Pharmaceuticals Inc Borsa (MDGL) Ultime notizie

Mar 14, 2026

Madrigal Pharmaceuticals presence at Liver Connect Conference as attendance doubles - Traders Union

Mar 14, 2026

Madrigal Pharmaceuticals grants equity awards to 20 new employees - MSN

Mar 14, 2026

Is Rezdiffra’s Near‑US$1 Billion Debut Reshaping The Investment Case For Madrigal Pharmaceuticals (MDGL)? - simplywall.st

Mar 14, 2026

Mar 12, 2026

Assessing Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Pullback - simplywall.st

Mar 12, 2026

Barclays PLC Cuts Stock Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Mar 12, 2026

Mar 11, 2026

Madrigal Pharmaceuticals Grants Equity Awards to 20 New Employees - MyChesCo

Mar 11, 2026

Is Madrigal Pharmaceuticals (MDGL) Pricing Look Interesting After Long Term Share Price Surge? - Yahoo Finance

Mar 11, 2026

Mar 10, 2026

2 Under-the-Radar Stocks to Buy and Hold - The Globe and Mail

Mar 10, 2026

What Makes Madrigal Pharma (MDGL) One of the Shorted Biotech Stocks to Buy - Finviz

Mar 10, 2026

Fieldview Capital Management LLC Invests $2.14 Million in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Mar 10, 2026

Rhenman & Partners Asset Management AB Purchases Shares of 18,250 Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Mar 08, 2026

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 08, 2026

Mar 07, 2026

Madrigal Pharmaceuticals EVP Dier sells $854k in stock By Investing.com - Investing.com South Africa

Mar 07, 2026

Madrigal Pharmaceuticals EVP Dier sells $854k in stock - Investing.com Nigeria

Mar 07, 2026

Mar 06, 2026

Pharma News: Why Madrigal Pharmaceuticals Inc. stock could be next big winnerTrade Volume Report & High Accuracy Swing Entry Alerts - Naître et grandir

Mar 06, 2026

Madrigal Pharmaceuticals (NASDAQ:MDGL) CFO Sells $853,984.34 in Stock - MarketBeat

Mar 06, 2026

Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells $718,316.22 in Stock - MarketBeat

Mar 06, 2026

Market Review: Why Madrigal Pharmaceuticals Inc. stock could be next big winnerPortfolio Update Summary & Stock Timing and Entry Methods - Naître et grandir

Mar 06, 2026

Madrigal Pharmaceuticals (NASDAQ:MDGL) General Counsel Sells $155,498.40 in Stock - MarketBeat

Mar 06, 2026

Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells 491 Shares of Stock - MarketBeat

Mar 06, 2026

Madrigal Pharmaceuticals CEO Sibold sells $718k in shares By Investing.com - Investing.com Canada

Mar 06, 2026

Madrigal (NASDAQ: MDGL) CFO sells stock and gets new equity grants - Stock Titan

Mar 06, 2026

Madrigal Pharmaceuticals general counsel sells $155k in stock By Investing.com - Investing.com Canada

Mar 06, 2026

Madrigal Pharmaceuticals CEO Sibold sells $718k in shares - Investing.com

Mar 06, 2026

Madrigal Pharmaceuticals (MDGL) GC gets equity grants and tax sale - Stock Titan

Mar 06, 2026

Madrigal (NASDAQ: MDGL) CCO logs tax sale and new equity grants - Stock Titan

Mar 06, 2026

Insider sales by Madrigal (MDGL) include 24,800 and 18,650-share trades - Stock Titan

Mar 06, 2026

Madrigal Pharmaceuticals (MDGL) reports record 2025 revenue driven by Rezdiffra success - MSN

Mar 06, 2026

Teachers Retirement System of The State of Kentucky Invests $1.32 Million in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Mar 06, 2026

Mar 05, 2026

Madrigal gains after Rezdiffra patent win - MSN

Mar 05, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 05, 2026

Aug Shorts: Will UnitedHealth Group Incorporated stock go up in YEARQuarterly Performance Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn

Mar 05, 2026

Risk Check: Can Madrigal Pharmaceuticals Inc weather a recessionWeekly Stock Analysis & Safe Entry Momentum Stock Tips - baoquankhu1.vn

Mar 05, 2026

Segall Bryant & Hamill LLC Invests $10.32 Million in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Mar 05, 2026

20 new Madrigal staff get stock options and 6,882 RSUs at $432 - Stock Titan

Mar 05, 2026

A Look At Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Weakness - simplywall.st

Mar 05, 2026

Mar 04, 2026

Madrigal Pharmaceuticals: How Noninvasive Data Is Powering a Smarter Clinical Strategy! - Smartkarma

Mar 04, 2026